ArticleP & T : a peer-reviewed journal for formulary management2015

Ledipasvir/Sofosbuvir (harvoni): improving options for hepatitis C virus infection.

Diana Gritsenko et al.PubMed ↗Full text ↗

No numbers read from the abstract.